Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Nebivolol is a new beta 1 selective blocker with vasodilatation properties via activation of the L-arginine/nitric oxide pathway. Short-term studies, and a long-term, open-label study, have shown excellent efficacy and safety in stages 1-11 hypertension.

Nebivolol for Hypertension